High-flow Nasal Cannula Oxygen Therapy and Hypoxia/Desaturation During Percutaneous Radiofrequency Ablation Under Moderate Sedation: A Randomized Clinical Trial

Status: Completed
Location: See location...
Intervention Type: Other, Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Background: Propofol based sedated anesthesia was widely used in percutaneous radiofrequency ablation and hypoxia/desaturation is one of the most frequent adverse events during this procedure. No effective methods have been found to prevent hypoxia/desaturation so far. The aim of this study was to evaluate whether the incidence of hypoxia/desaturation was different between the high-flow nasal cannula (HFNC) therapy group (which can provide heated and humidified oxygen up to 60L/minute.) and the nasal cannula group.

Methods: In a randomized, prospective and double-blind study,100 patients undergo percutaneous radiofrequency ablation based on propofol sedation were assigned into two groups: the nasal cannula group (O2 \[6 L/minute\] was supplied via an HFNC) and the HFNC group (O2 \[40 L/minute\] was supplied via an HFNC). The primary outcome is the incidence of hypoxia/desaturation during surgery. Other adverse events were also recorded.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• 18\< age \< 75 years;

• ASA physical state I and II; .Undergoing percutaneous radiofrequency ablation.

Locations
Other Locations
China
Zhejiang Cancer hospital
Hangzhou
Time Frame
Start Date: 2022-01-01
Completion Date: 2023-08-17
Participants
Target number of participants: 100
Treatments
Sham_comparator: Nasal cannula group
Heated and humidified oxygen of 6 L/minute was supplied via an HFNC
Experimental: High-flow nasal cannula (HFNC)
Heated and humidified oxygen of 40 L/minute was supplied via an HFNC
Related Therapeutic Areas
Sponsors
Leads: Zhejiang Cancer Hospital

This content was sourced from clinicaltrials.gov